BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28187999)

  • 1. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.
    Lai JKC; Robertson PL; Goh C; Szer J
    Blood Cells Mol Dis; 2018 Feb; 68():121-125. PubMed ID: 28187999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
    Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
    Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
    Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.
    Elstein D; Haims AH; Zahrieh D; Cohn GM; Zimran A
    Blood Cells Mol Dis; 2014; 53(1-2):56-60. PubMed ID: 24581483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
    Mariani G; Perri M; Minichilli F; Ortori S; Linari S; Giona F; Di Rocco M; Cappellini MD; Guidoccio F; Erba PA
    AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbar spine: reliability of MR imaging findings.
    Carrino JA; Lurie JD; Tosteson AN; Tosteson TD; Carragee EJ; Kaiser J; Grove MR; Blood E; Pearson LH; Weinstein JN; Herzog R
    Radiology; 2009 Jan; 250(1):161-70. PubMed ID: 18955509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
    Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
    Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
    Gan C; Robertson PL; Lai JKC; Szer J
    Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver and intraobserver variability in the sonographic assessment of fatty liver.
    Strauss S; Gavish E; Gottlieb P; Katsnelson L
    AJR Am J Roentgenol; 2007 Dec; 189(6):W320-3. PubMed ID: 18029843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of a modified Modic classification of bone marrow changes in lumbar spine MRI.
    Fayad F; Lefevre-Colau MM; Drapé JL; Feydy A; Chemla N; Quintéro N; Rannou F; Poiraudeau S; Fermanian J; Revel M
    Joint Bone Spine; 2009 May; 76(3):286-9. PubMed ID: 19119042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional endoanal ultrasonography: intraobserver and interobserver agreement using scoring systems for classification of anal sphincter defects.
    Norderval S; Dehli T; Vonen B
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):337-43. PubMed ID: 19224542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Agreement of Different Spine Fracture Classification Systems: An Independent Intraobserver and Interobserver Study.
    Pishnamaz M; Balosu S; Curfs I; Uhing D; Laubach M; Herren C; Weber C; Hildebrand F; Willems P; Kobbe P
    World Neurosurg; 2018 Jul; 115():e695-e702. PubMed ID: 29709750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced vertebra to disk ratio as a new semi-quantitative imaging biomarker for Gaucher disease patients.
    Beaumont H; Maas M; Wormanns D; Zaim S; Klifa C; Faye N; Iannessi A
    Eur J Radiol; 2020 Aug; 129():109091. PubMed ID: 32497944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
    Serai SD; Naidu AP; Andrew Burrow T; Prada CE; Xanthakos S; Towbin AJ
    Mol Genet Metab; 2018 Mar; 123(3):357-363. PubMed ID: 29361370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow abnormalities of foot and ankle: STIR versus T1-weighted contrast-enhanced fat-suppressed spin-echo MR imaging.
    Schmid MR; Hodler J; Vienne P; Binkert CA; Zanetti M
    Radiology; 2002 Aug; 224(2):463-9. PubMed ID: 12147843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement in the interpretation of magnetic resonance images of the lumbar spine.
    Kovacs FM; Royuela A; Jensen TS; Estremera A; Amengual G; Muriel A; Galarraga I; Martínez C; Arana E; Sarasíbar H; Salgado RM; Abraira V; López O; Campillo C; del Real MT; Zamora J
    Acta Radiol; 2009 Jun; 50(5):497-506. PubMed ID: 19431057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.